Dietary Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Comparing Mediterranean, Low-Carbohydrate, Ketogenic, and Time-Restricted Eating Approaches

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic liver disorder closely associated with obesity, insulin resistance, dyslipidemia, and other cardiometabolic risk factors. Lifestyle modification, particularly dietary intervention, remains a cornerstone of MASLD management; however, the optimal dietary strategy for improving hepatic steatosis and metabolic health remains incompletely established. This review examines and compares the evidence supporting four dietary approaches Mediterranean, lowcarbohydrate, ketogenic, and time-restricted eating in the management of MASLD. Particular attention is given to their effects on hepatic fat accumulation, body weight, insulin sensitivity, glycemic control, lipid metabolism, and other relevant metabolic and liver-related outcomes. The Mediterranean diet is characterized by a high intake of vegetables, fruits, whole grains, legumes, nuts, and olive oil, and has demonstrated consistent benefits for overall metabolic health and cardiovascular risk, with emerging evidence supporting improvements in hepatic steatosis. Low-carbohydrate and ketogenic diets may promote substantial weight loss and improve glycemic and insulin-related parameters, potentially contributing to reductions in liver fat; however, their long-term efficacy, sustainability, and nutritional adequacy require further consideration. Time-restricted eating represents a potentially practical approach that modifies the timing of food intake rather than prescribing specific macronutrient compositions and may improve metabolic outcomes through weight loss and enhanced circadian metabolic regulation. Across these dietary strategies, improvements in MASLD appear to be influenced substantially by energy restriction, weight reduction, dietary quality, adherence, and individual metabolic characteristics. Current evidence therefore does not support a universally superior dietary pattern for all patients with MASLD. Instead, dietary management should be individualized according to metabolic status, nutritional preferences, comorbidities, lifestyle factors, and the likelihood of long-term adherence. Further well-designed, adequately powered, long-term randomized controlled trials are needed to directly compare these approaches and clarify their independent effects on liver-specific outcomes. Overall, integrating dietary quality, sustainable weight management, and individualized eating patterns may provide the most effective framework for nutritional management of MASLD.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-19
DOI
https://doi.org/10.25258/ijddt.16.80s.62
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dietary Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Comparing Mediterranean, Low-Carbohydrate, Ketogenic, and Time-Restricted Eating Approaches

Manal Mused Almatrafi
4 links
International Journal of Drug Delivery Technology
Liver Disease Diagnosis and Treatment
article

Dietary Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Comparing Mediterranean, Low-Carbohydrate, Ketogenic, and Time-Restricted Eating Approaches

Manal Mused Almatrafi
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic liver disorder closely associated with obesity, insulin resistance, dyslipidemia, and other cardiometabolic risk factors. Lifestyle modification, particularly dietary intervention, remains a cornerstone of MASLD management; however, the optimal dietary strategy for improving hepatic steatosis and metabolic health remains incompletely established. This review examines and compares the evidence supporting four dietary approaches Mediterranean, lowcarbohydrate, ketogenic, and time-restricted eating in the management of MASLD. Particular attention is given to their effects on hepatic fat accumulation, body weight, insulin sensitivity, glycemic control, lipid metabolism, and other relevant metabolic and liver-related outcomes. The Mediterranean diet is characterized by a high intake of vegetables, fruits, whole grains, legumes, nuts, and olive oil, and has demonstrated consistent benefits for overall metabolic health and cardiovascular risk, with emerging evidence supporting improvements in hepatic steatosis. Low-carbohydrate and ketogenic diets may promote substantial weight loss and improve glycemic and insulin-related parameters, potentially contributing to reductions in liver fat; however, their long-term efficacy, sustainability, and nutritional adequacy require further consideration. Time-restricted eating represents a potentially practical approach that modifies the timing of food intake rather than prescribing specific macronutrient compositions and may improve metabolic outcomes through weight loss and enhanced circadian metabolic regulation. Across these dietary strategies, improvements in MASLD appear to be influenced substantially by energy restriction, weight reduction, dietary quality, adherence, and individual metabolic characteristics. Current evidence therefore does not support a universally superior dietary pattern for all patients with MASLD. Instead, dietary management should be individualized according to metabolic status, nutritional preferences, comorbidities, lifestyle factors, and the likelihood of long-term adherence. Further well-designed, adequately powered, long-term randomized controlled trials are needed to directly compare these approaches and clarify their independent effects on liver-specific outcomes. Overall, integrating dietary quality, sustainable weight management, and individualized eating patterns may provide the most effective framework for nutritional management of MASLD.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Taif University (SA)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon